Teva Pharmaceutical Industries Limited (TEVA)Healthcare | Drug Manufacturers - Specialty & Generic | Tel Aviv-Yafo, Israel | NYSE
40.72 USD
-0.53
(-1.285%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 41.00 +0.28 (0.688%) ⇧ (Oct. 14, 2026, 4:24 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 5:48 a.m. EDT
The immediate catalyst here is the company's successful pivot to branded drugs, highlighted by revenue guidance that exceeded expectations and a stock price reacting positively to the news. While the statistical forecasting model offers no directional bias due to low confidence, the options market is clearly leaning bullish, with traders buying calls at strikes significantly higher than the current price. However, the long-term outlook remains murky; despite the recent recovery, the multi-year price trajectory shows a massive cumulative decline of over 55%, indicating that the market still views the underlying business as fundamentally impaired or struggling to regain its footing. The balance sheet is fragile with debt-to-equity exceeding 200, and the lack of any dividend history suggests capital preservation is not a priority. Investors should view the recent gains as a speculative bet on the turnaround story rather than a confirmation of restored health, keeping the long-term rating neutral until the balance sheet strengthens and consistent growth is proven. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.058227 |
| AutoETS | 0.058229 |
| AutoTheta | 0.058380 |
| MSTL | 0.064437 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 11.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.447 |
| Excess Kurtosis | -0.92 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2017-11-27 |
| Last Dividend Date | 2017-11-26 |
| Debt to Equity Ratio | 217.79 |
| Revenue per Share | 15.004 |
| Market Cap | 47,491,436,544 |
| Trailing P/E | 67.87 |
| Forward P/E | 13.17 |
| Beta | 0.82 |
| Profit Margins | 4.08% |
| Website | https://www.tevapharm.com |
As of Oct. 10, 2026, 5:48 a.m. EDT: Speculators are positioning for a moderate upside move, evidenced by heavy call volume and open interest at strikes above the current price (42, 43, 44, 45), particularly in the November and December expirations. This bullish flow contrasts sharply with the put side, which shows significant open interest at deep out-of-the-money strikes (15, 23, 30, 31) suggesting a hedge against a severe crash rather than active bearish betting. Implied volatility is elevated relative to historical norms, reflecting uncertainty around the earnings pivot.
| Date | Dividend | Yield % |
|---|---|---|
| 2017-11-27 | 0.085000 | 0.580205 |
| 2017-08-25 | 0.085000 | 0.524368 |
| 2017-06-01 | 0.340000 | 1.172010 |
| 2017-02-28 | 0.340000 | 0.970874 |
| 2016-12-01 | 0.340000 | 0.929724 |
| 2016-08-18 | 0.340000 | 0.640905 |
| 2016-05-20 | 0.340000 | 0.654601 |
| 2016-02-25 | 0.340000 | 0.590483 |
| 2015-11-13 | 0.340000 | 0.586106 |
| 2015-08-18 | 0.340000 | 0.492539 |
| 2015-05-15 | 0.340000 | 0.564503 |
| 2015-02-17 | 0.340000 | 0.596491 |
| 2014-11-13 | 0.321000 | 0.561483 |
| 2014-08-19 | 0.353000 | 0.668687 |
| 2014-05-16 | 0.347000 | 0.696647 |
| 2014-02-20 | 0.345000 | 0.715768 |
| 2013-11-18 | 0.326000 | 0.853403 |
| 2013-08-16 | 0.322000 | 0.803794 |
| 2013-05-16 | 0.320000 | 0.800801 |
| 2013-02-19 | 0.310000 | 0.807712 |
| 2012-11-13 | 0.257000 | 0.650963 |
| 2012-08-13 | 0.249000 | 0.611944 |
| 2012-05-17 | 0.261000 | 0.672854 |
| 2012-02-23 | 0.267000 | 0.599596 |
| 2011-11-09 | 0.219000 | 0.539675 |
| 2011-08-04 | 0.235000 | 0.569559 |
| 2011-05-19 | 0.232000 | 0.461967 |
| 2011-02-10 | 0.215000 | 0.416667 |
| 2010-11-08 | 0.193000 | 0.379473 |
| 2010-08-02 | 0.181000 | 0.360414 |
| 2010-05-10 | 0.188000 | 0.317675 |
| 2010-02-19 | 0.186000 | 0.316650 |
| 2009-11-06 | 0.158000 | 0.303671 |
| 2009-08-03 | 0.154000 | 0.287421 |
| 2009-05-08 | 0.145000 | 0.329321 |
| 2009-02-23 | 0.148000 | 0.327000 |
| 2008-11-07 | 0.117000 | 0.274971 |
| 2008-08-01 | 0.130000 | 0.282057 |
| 2008-05-13 | 0.131000 | 0.292085 |
| 2008-02-15 | 0.125000 | 0.266468 |
| 2007-11-02 | 0.101000 | 0.229233 |
| 2007-08-10 | 0.092000 | 0.212324 |
| 2007-05-10 | 0.098000 | 0.254876 |
| 2007-02-16 | 0.094000 | 0.249271 |
| 2006-11-10 | 0.079000 | 0.249921 |
| 2006-08-11 | 0.078000 | 0.226021 |
| 2006-05-12 | 0.077000 | 0.205224 |
| 2006-03-06 | 0.072000 | 0.173703 |
| 2005-11-10 | 0.064000 | 0.161412 |
| 2005-08-11 | 0.067000 | 0.204082 |
| 2005-05-05 | 0.069000 | 0.218424 |
| 2005-02-17 | 0.069000 | 0.256315 |
| 2004-11-09 | 0.051000 | 0.200551 |
| 2004-08-09 | 0.050000 | 0.178380 |
| 2004-05-10 | 0.049000 | 0.157177 |
| 2004-02-20 | 0.050500 | 0.156057 |
| 2003-11-13 | 0.036500 | 0.127712 |
| 2003-08-08 | 0.037500 | 0.136190 |
| 2003-05-08 | 0.037000 | 0.157313 |
| 2003-02-24 | 0.034000 | 0.184732 |
| 2003-01-07 | 0.017500 | 0.089286 |
| 2002-11-07 | 0.022500 | 0.122150 |
| 2002-08-19 | 0.022750 | 0.132306 |
| 2002-05-20 | 0.022000 | 0.135031 |
| 2002-02-15 | 0.023250 | 0.156303 |
| 2001-11-16 | 0.016000 | 0.110326 |
| 2001-08-20 | 0.016000 | 0.089888 |
| 2001-05-17 | 0.016250 | 0.118332 |
| 2001-03-08 | 0.016500 | 0.113305 |
| 2000-11-16 | 0.013750 | 0.088000 |
| 2000-08-24 | 0.014000 | 0.086320 |
| 2000-05-19 | 0.013500 | 0.114135 |
| 1999-11-04 | 0.006625 | 0.105736 |
| 1999-08-18 | 0.006875 | 0.116402 |
| 1999-05-21 | 0.006875 | 0.108911 |
| 1999-03-08 | 0.007250 | 0.132006 |
| 1998-11-20 | 0.008125 | 0.150725 |
| 1998-11-16 | 0.008125 | 0.150289 |
| 1998-08-21 | 0.008125 | 0.166667 |
| 1998-05-21 | 0.008125 | 0.156391 |
| 1998-03-12 | 0.008500 | 0.161905 |
| 1997-11-20 | 0.008500 | 0.138599 |
| 1997-08-25 | 0.008500 | 0.123636 |
| 1997-05-23 | 0.007500 | 0.102128 |
| 1997-03-07 | 0.006500 | 0.081409 |
| 1996-11-20 | 0.006250 | 0.111111 |
| 1996-08-26 | 0.006250 | 0.137931 |
| 1996-05-23 | 0.006250 | 0.106101 |
| 1996-03-07 | 0.006250 | 0.118694 |
| 1995-11-20 | 0.006250 | 0.123267 |
| 1995-08-14 | 0.006250 | 0.122699 |
| 1995-05-17 | 0.008125 | 0.192950 |
| 1995-03-07 | 0.006500 | 0.188235 |
| 1994-11-15 | 0.006000 | 0.183732 |
| 1994-08-09 | 0.006250 | 0.180180 |
| 1994-03-08 | 0.005250 | 0.138843 |
| 1993-11-17 | 0.004625 | 0.122314 |
| 1993-08-17 | 0.004625 | 0.147264 |
| 1993-05-18 | 0.004375 | 0.150538 |
| 1993-04-07 | 0.002500 | 0.094395 |
| 1992-11-17 | 0.002500 | 0.123552 |
| 1992-08-18 | 0.003125 | 0.192308 |
| 1992-05-19 | 0.002625 | 0.168844 |
| 1992-03-03 | 0.002188 | 0.132732 |
| 1991-11-20 | 0.002188 | 0.205929 |
| 1991-08-21 | 0.002188 | 0.193148 |
| 1991-05-20 | 0.002500 | 0.273504 |
| 1991-03-05 | 0.002500 | 0.283186 |
| 1990-11-20 | 0.002313 | 0.314962 |
| 1990-08-17 | 0.002313 | 0.336436 |
| 1990-05-21 | 0.002188 | 0.325656 |
| 1990-03-08 | 0.002375 | 0.353488 |
| 1989-11-20 | 0.001938 | 0.275627 |
| 1989-08-16 | 0.001875 | 0.307692 |
| 1989-05-22 | 0.001938 | 0.354377 |
| 1989-03-09 | 0.002313 | 0.548267 |
| 1988-12-06 | 0.001875 | 0.452830 |
| 1988-09-08 | 0.002250 | 0.564705 |
| 1988-06-10 | 0.001750 | 0.471579 |
| 1988-04-12 | 0.001875 | 0.444444 |
| 1988-02-08 | 0.001875 | 0.600000 |
| 1987-10-23 | 0.001875 | 0.436363 |
| 1987-07-09 | 0.002375 | 0.361905 |
| 1987-06-22 | 0.001875 | 0.279070 |
| 1987-02-23 | 0.001875 | 0.342857 |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0854399 |
| Address1 | 124 Dvora HaNevi’a St. |
| All Time High | 72.31 |
| All Time Low | 0.0625 |
| Ask | 41.75 |
| Ask Size | 200 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 6,475,360 |
| Average Daily Volume3 Month | 5,532,970 |
| Average Volume | 5,532,970 |
| Average Volume10Days | 6,475,360 |
| Beta | 0.817 |
| Bid | 40.62 |
| Bid Size | 300 |
| Board Risk | 3 |
| Book Value | 6.653 |
| City | Tel Aviv-Yafo |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 40.72 |
| Current Ratio | 0.879 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 41.87 |
| Day Low | 40.71 |
| Debt To Equity | 217.79 |
| Display Name | Teva Pharmaceutical Industries |
| Dividend Date | 1,513,036,800 |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,736,000 |
| Earnings Call Timestamp Start | 1,793,736,000 |
| Earnings Timestamp | 1,793,736,000 |
| Earnings Timestamp End | 1,793,736,000 |
| Earnings Timestamp Start | 1,793,736,000 |
| Ebitda | 4,268,000,000 |
| Ebitda Margins | 0.24649 |
| Enterprise To Ebitda | 14.365 |
| Enterprise To Revenue | 3.541 |
| Enterprise Value | 61,311,463,424 |
| Eps Current Year | 2.10669 |
| Eps Forward | 3.09227 |
| Eps Trailing Twelve Months | 0.6 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,511,827,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 37.8788 |
| Fifty Day Average Change | 2.8412018 |
| Fifty Day Average Change Percent | 0.07500771 |
| Fifty Two Week Change Percent | 108.54399 |
| Fifty Two Week High | 42.02 |
| Fifty Two Week High Change | -1.2999992 |
| Fifty Two Week High Change Percent | -0.03093763 |
| Fifty Two Week Low | 18.83 |
| Fifty Two Week Low Change | 21.890001 |
| Fifty Two Week Low Change Percent | 1.1625067 |
| Fifty Two Week Range | 18.83 - 42.02 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 382,717,800,000 |
| Five Year Avg Dividend Yield | 1.79 |
| Float Shares | 1,088,782,743 |
| Forward Eps | 3.09227 |
| Forward P E | 13.168321 |
| Free Cashflow | 2,219,875,072 |
| Full Exchange Name | NYSE |
| Full Time Employees | 31,173 |
| Fullday Change | 0.08000183 |
| Fullday Change Percent | 0.19432071 |
| Fullday Price | 41.0 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.52457 |
| Gross Profits | 9,082,999,808 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0056 |
| Held Percent Institutions | 0.24605 |
| Implied Shares Outstanding | 1,166,292,643 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,511,740,800 |
| Last Dividend Value | 0.085 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,088,640,000 |
| Last Split Factor | 2:1 |
| Long Business Summary | Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel. |
| Long Name | Teva Pharmaceutical Industries Limited |
| Market | us_market |
| Market Cap | 47,491,436,544 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_308047 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 706,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 44,347,287,915 |
| Number Of Analyst Opinions | 12 |
| Open | 41.11 |
| Operating Cashflow | 1,898,000,000 |
| Operating Margins | 0.04032 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.71 |
| Phone | 972 3 914 8213 |
| Post Market Change | 0.27999878 |
| Post Market Change Percent | 0.68761975 |
| Post Market Price | 41.0 |
| Post Market Time | 1,792,009,456 |
| Previous Close | 41.25 |
| Price Eps Current Year | 19.328901 |
| Price Hint | 2 |
| Price To Book | 6.1205473 |
| Price To Sales Trailing12 Months | 2.7427917 |
| Profit Margins | 0.04077 |
| Quick Ratio | 0.457 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.46154 |
| Region | US |
| Regular Market Change | -0.5299988 |
| Regular Market Change Percent | -1.2848456 |
| Regular Market Day High | 41.87 |
| Regular Market Day Low | 40.71 |
| Regular Market Day Range | 40.71 - 41.87 |
| Regular Market Open | 41.11 |
| Regular Market Previous Close | 41.25 |
| Regular Market Price | 40.72 |
| Regular Market Time | 1,792,008,002 |
| Regular Market Volume | 9,831,150 |
| Return On Assets | 0.05126 |
| Return On Equity | 0.09691 |
| Revenue Growth | -0.008 |
| Revenue Per Share | 15.004 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 1,166,292,643 |
| Shares Percent Shares Out | 0.0256 |
| Shares Short | 29,848,805 |
| Short Name | Teva Pharmaceutical Industries |
| Short Percent Of Float | 0.0257 |
| Short Ratio | 9.08 |
| Source Interval | 15 |
| Symbol | TEVA |
| Target High Price | 55.0 |
| Target Low Price | 42.0 |
| Target Mean Price | 47.16667 |
| Target Median Price | 47.5 |
| Total Cash | 3,655,000,064 |
| Total Cash Per Share | 3.137 |
| Total Debt | 16,894,000,128 |
| Total Revenue | 17,315,000,320 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.6 |
| Trailing P E | 67.86667 |
| Trailing Peg Ratio | 0.7131 |
| Triggerable | 1 |
| Two Hundred Day Average | 34.007 |
| Two Hundred Day Average Change | 6.7130013 |
| Two Hundred Day Average Change Percent | 0.19740057 |
| Type Disp | Equity |
| Volume | 9,831,150 |
| Website | https://www.tevapharm.com |
| Zip | 6,944,020 |